Queen Mary University London

Neuroscience PGCert

The Neuroscience PGCert at Queen Mary University of London is designed to advance your career in neuroscience by exploring critical areas such as drug development, neurological disease management, and clinical trial methodologies. This programme uniquely integrates scientific, clinical, and personal aspects of neurological diseases, providing a comprehensive understanding of translational medicine. Students will gain a solid grounding in the principles of drug design and development, focusing on the challenges of creating effective therapies for nervous system diseases. The curriculum includes in-depth studies of laboratory methods and models used in drug discovery, alongside the specific methodologies employed in clinical trials.

One of the standout features of this course is its emphasis on the clinical challenges faced in neurological diseases, making it distinct from other programmes. Students will engage with world-leading experts through interactive sessions, gaining insights into areas such as brain tumours, neurodegenerative diseases, and neuroinflammation. The course structure includes one compulsory module and one elective module, allowing for tailored learning experiences.

The compulsory module, 'Fundamentals of Drug Discovery and Drug Development', covers essential components of translational medicine, including drug targets, clinical trials, and regulatory aspects. Elective modules offer further specialisation in topics like neuroinflammatory diseases, neuro-oncology, and neurodegenerative diseases. The programme is supported by a dedicated team of specialists, ensuring a rich learning environment. With a 100% overall satisfaction rating from students, this PGCert is an excellent choice for those looking to make a significant impact in the field of neuroscience.